Annual gross profit:
$19.66B-$952.16M(-4.62%)Summary
- As of today (April 17, 2025), TAK annual gross profit is $19.66 billion, with the most recent change of -$952.16 million (-4.62%) on March 31, 2024.
- During the last 3 years, TAK annual gross profit has fallen by -$1.13 billion (-5.41%).
- TAK annual gross profit is now -10.36% below its all-time high of $21.93 billion, reached on March 31, 2022.
Performance
TAK Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$4.77B-$494.99M(-9.41%)Summary
- As of today (April 17, 2025), TAK quarterly gross profit is $4.77 billion, with the most recent change of -$494.99 million (-9.41%) on December 1, 2024.
- Over the past year, TAK quarterly gross profit has dropped by -$494.99 million (-9.41%).
- TAK quarterly gross profit is now -26.32% below its all-time high of $6.47 billion, reached on June 30, 2021.
Performance
TAK quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$19.80B-$187.64M(-0.94%)Summary
- As of today (April 17, 2025), TAK TTM gross profit is $19.80 billion, with the most recent change of -$187.64 million (-0.94%) on December 1, 2024.
- Over the past year, TAK TTM gross profit has dropped by -$187.64 million (-0.94%).
- TAK TTM gross profit is now -10.44% below its all-time high of $22.11 billion, reached on September 30, 2021.
Performance
TAK TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
TAK Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.6% | -9.4% | -0.9% |
| 3 y3 years | -5.4% | -2.6% | -3.8% |
| 5 y5 years | +50.8% | -2.3% | -4.8% |
TAK Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.4% | at low | -11.6% | +5.9% | -9.8% | +1.2% |
| 5 y | 5-year | -10.4% | at low | -26.3% | +5.9% | -10.4% | +1.2% |
| alltime | all time | -10.4% | +344.3% | -26.3% | +95.3% | -10.4% | +527.0% |
Takeda Pharmaceutical Company Limited Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $4.77B(-9.4%) | $19.80B(-0.9%) |
| Sep 2024 | - | $5.26B(-0.1%) | $19.99B(+2.1%) |
| Jun 2024 | - | $5.27B(+17.0%) | $19.57B(-0.5%) |
| Mar 2024 | $19.66B(-4.6%) | $4.50B(-9.1%) | $19.68B(-1.9%) |
| Dec 2023 | - | $4.96B(+2.3%) | $20.07B(-2.1%) |
| Sep 2023 | - | $4.84B(-9.9%) | $20.51B(-1.0%) |
| Jun 2023 | - | $5.37B(+9.8%) | $20.71B(+0.6%) |
| Mar 2023 | $20.61B(-6.0%) | $4.89B(-9.3%) | $20.58B(+0.2%) |
| Dec 2022 | - | $5.39B(+6.9%) | $20.55B(-0.3%) |
| Sep 2022 | - | $5.04B(-3.8%) | $20.60B(-0.6%) |
| Jun 2022 | - | $5.24B(+7.9%) | $20.73B(-5.6%) |
| Mar 2022 | $21.93B(+5.5%) | $4.86B(-10.8%) | $21.96B(-0.1%) |
| Dec 2021 | - | $5.45B(+5.5%) | $21.97B(-0.6%) |
| Sep 2021 | - | $5.17B(-20.1%) | $22.11B(+0.4%) |
| Jun 2021 | - | $6.47B(+32.6%) | $22.02B(+5.9%) |
| Mar 2021 | $20.79B(+2.6%) | $4.88B(-12.7%) | $20.79B(+0.4%) |
| Dec 2020 | - | $5.59B(+10.0%) | $20.72B(+1.3%) |
| Sep 2020 | - | $5.08B(-3.0%) | $20.46B(+0.2%) |
| Jun 2020 | - | $5.24B(+9.0%) | $20.42B(+0.8%) |
| Mar 2020 | $20.25B(+55.3%) | $4.81B(-9.8%) | $20.25B(+4.4%) |
| Dec 2019 | - | $5.33B(+5.7%) | $19.40B(+12.3%) |
| Sep 2019 | - | $5.04B(-0.6%) | $17.27B(+14.4%) |
| Jun 2019 | - | $5.07B(+28.3%) | $15.10B(+15.7%) |
| Mar 2019 | $13.04B(+13.3%) | $3.95B(+23.5%) | $13.04B(+10.9%) |
| Dec 2018 | - | $3.20B(+11.5%) | $11.77B(+1.2%) |
| Sep 2018 | - | $2.87B(-4.9%) | $11.63B(+0.6%) |
| Jun 2018 | - | $3.02B(+12.8%) | $11.56B(+0.6%) |
| Mar 2018 | $11.50B(+6.0%) | $2.68B(-12.6%) | $11.49B(+1.8%) |
| Dec 2017 | - | $3.06B(+9.1%) | $11.29B(+1.4%) |
| Sep 2017 | - | $2.81B(-4.7%) | $11.14B(+1.1%) |
| Jun 2017 | - | $2.95B(+18.9%) | $11.02B(+1.7%) |
| Mar 2017 | $10.85B(+2.3%) | $2.48B(-14.8%) | $10.84B(+0.3%) |
| Dec 2016 | - | $2.91B(+8.2%) | $10.81B(+0.7%) |
| Sep 2016 | - | $2.69B(-2.7%) | $10.73B(+0.6%) |
| Jun 2016 | - | $2.76B(+13.2%) | $10.67B(+0.8%) |
| Mar 2016 | $10.60B | $2.44B(-13.8%) | $10.59B(-1.0%) |
| Dec 2015 | - | $2.83B(+7.7%) | $10.69B(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $2.63B(-1.8%) | $10.91B(-3.2%) |
| Jun 2015 | - | $2.68B(+5.3%) | $11.27B(-1.6%) |
| Mar 2015 | $11.49B(-4.2%) | $2.55B(-16.6%) | $11.46B(-1.9%) |
| Dec 2014 | - | $3.05B(+2.0%) | $11.68B(-1.7%) |
| Sep 2014 | - | $2.99B(+4.4%) | $11.89B(-0.1%) |
| Jun 2014 | - | $2.87B(+3.9%) | $11.90B(-0.8%) |
| Mar 2014 | $12.00B(-9.3%) | $2.76B(-15.2%) | $11.99B(+1.3%) |
| Dec 2013 | - | $3.26B(+8.3%) | $11.84B(-1.7%) |
| Sep 2013 | - | $3.01B(+1.7%) | $12.05B(-4.0%) |
| Jun 2013 | - | $2.96B(+13.3%) | $12.55B(-5.4%) |
| Mar 2013 | $13.23B(-2.9%) | $2.61B(-24.7%) | $13.27B(-4.2%) |
| Dec 2012 | - | $3.47B(-1.1%) | $13.85B(-1.0%) |
| Sep 2012 | - | $3.51B(-4.7%) | $14.00B(+0.8%) |
| Jun 2012 | - | $3.68B(+15.2%) | $13.89B(+2.0%) |
| Mar 2012 | $13.63B(+6.5%) | $3.20B(-11.6%) | $13.63B(+0.7%) |
| Dec 2011 | - | $3.61B(+6.1%) | $13.53B(+1.4%) |
| Sep 2011 | - | $3.40B(-0.2%) | $13.35B(+0.9%) |
| Jun 2011 | - | $3.41B(+9.9%) | $13.22B(+2.7%) |
| Mar 2011 | $12.80B(+0.5%) | $3.10B(-9.4%) | $12.87B(+1.2%) |
| Dec 2010 | - | $3.43B(+4.5%) | $12.71B(+0.8%) |
| Sep 2010 | - | $3.28B(+7.1%) | $12.61B(-0.1%) |
| Jun 2010 | - | $3.06B(+3.8%) | $12.62B(-0.8%) |
| Mar 2010 | $12.73B(+1.3%) | $2.95B(-11.2%) | $12.71B(+0.7%) |
| Dec 2009 | - | $3.32B(+0.9%) | $12.62B(-0.6%) |
| Sep 2009 | - | $3.29B(+4.1%) | $12.70B(+1.0%) |
| Jun 2009 | - | $3.16B(+10.5%) | $12.57B(+33.5%) |
| Mar 2009 | $12.56B(+30.6%) | $2.86B(-15.9%) | $9.41B(+43.6%) |
| Dec 2008 | - | $3.40B(+7.6%) | $6.56B(+107.6%) |
| Sep 2008 | - | $3.16B | $3.16B |
| Mar 2008 | $9.62B(+9.7%) | - | - |
| Mar 2007 | $8.77B(+6.6%) | - | - |
| Mar 2006 | $8.23B(+4.6%) | - | - |
| Mar 2005 | $7.86B(+8.5%) | - | - |
| Mar 2004 | $7.25B(+18.3%) | - | - |
| Mar 2003 | $6.13B(+14.6%) | - | - |
| Mar 2002 | $5.34B(+1.8%) | - | - |
| Mar 2001 | $5.25B(+18.7%) | - | - |
| Mar 2000 | $4.43B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual gross profit?
- What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit?
- What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM gross profit?
- What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
What is Takeda Pharmaceutical Company Limited annual gross profit?
The current annual gross profit of TAK is $19.66B
What is the all time high annual gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual gross profit is $21.93B
What is Takeda Pharmaceutical Company Limited annual gross profit year-on-year change?
Over the past year, TAK annual gross profit has changed by -$952.16M (-4.62%)
What is Takeda Pharmaceutical Company Limited quarterly gross profit?
The current quarterly gross profit of TAK is $4.77B
What is the all time high quarterly gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly gross profit is $6.47B
What is Takeda Pharmaceutical Company Limited quarterly gross profit year-on-year change?
Over the past year, TAK quarterly gross profit has changed by -$494.99M (-9.41%)
What is Takeda Pharmaceutical Company Limited TTM gross profit?
The current TTM gross profit of TAK is $19.80B
What is the all time high TTM gross profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM gross profit is $22.11B
What is Takeda Pharmaceutical Company Limited TTM gross profit year-on-year change?
Over the past year, TAK TTM gross profit has changed by -$187.64M (-0.94%)